Search Results - "O'NEILL, C. J. A"

Refine Results
  1. 1

    Objective measurement of activation of rigidity: diagnostic, pathogenetic and therapeutic implications in parkinsonism by KIROLLOS, C., CHARLETT, A., O'NEILL, C. J. A., KOSIK, R., MOZOL, K., PURKISS, A. G., BOWES, S. G., NICHOLSON, P. W., HUNT, W. B., WELLER, C., DOBBS, S. M., DOBBS, R. J.

    Published in British journal of clinical pharmacology (01-06-1996)
    “…1Quantification of the effect on rigidity of its ‘activation’, by isometric grip, of standardized pressure, of the contralateral hand, was explored. Torque…”
    Get full text
    Journal Article
  2. 2

    Is This Walk Normal? by DOBBS, R. J., CHARLETT, A., BOWES, S. G., O'NEILL, C. J. A., WELLER, C., HUGHES, J., DOBBS, S. M.

    Published in Age and ageing (01-01-1993)
    “…Data from 144 volunteers, aged 30–89 years, judged to be healthy according to stated criteria, are used to construct speed and height-specific reference ranges…”
    Get full text
    Journal Article Conference Proceeding
  3. 3

    Hypothesis: Age-associated Changes in Gait Represent, in Part, a Tendency towards Parkinsonism by DOBBS, R. J., LUBEL, D. D., CHARLETT, A., BOWES, S. G., O'NEILL, C. J. A., WELLER, C., DOBBS, S. M.

    Published in Age and ageing (01-05-1992)
    “…In 144 healthy, active, asymptomatic volunteers (aged 30–88 years), age explained 33% of the variance in free walking speed. This could not be ascribed simply…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Quantification of the Cardinal Signs of Parkinsonism and of Associated Disability in Spouses of Sufferers by KIROLLOS, C., O'NEILL, C. J. A., DOBBS, R. J., CHARLETT, A., BOWES, S. G., WELLER, C., PURKISS, A. G., HUNT, W. B., DOBBS, S. M.

    Published in Age and ageing (01-01-1993)
    “…Work on the causation of idiopathic parkinsonism is limited by relying on gross clinical definition and lack of studies in the old. A prognostic index for…”
    Get full text
    Journal Article Conference Proceeding
  6. 6

    Assessment of the bradyphrenia of parkinsonism: a novel use of delayed auditory feedback by Dobbs, R J, Bowes, S G, Henley, M, Charlett, A, O'Neill, C J, Dickins, J, Nicholson, P W, Dobbs, S M

    Published in Acta neurologica Scandinavica (01-04-1993)
    “…Sufferers from parkinsonism have difficulty shifting or developing an appropriate mental set. Delayed auditory feedback may, therefore, disrupt their speech…”
    Get more information
    Journal Article
  7. 7

    Objective evidence for tolerance, against a background of improvement, during maintenance therapy with controlled release levodopa/carbidopa by BOWES, S. G, DOBBS, R. J, HENLEY, M, CHARLETT, A, O'NEILL, C. J. A, NICHOLSON, P. W, PURKISS, A. G, WELLER, C, DOBBS, S. M

    Published in European journal of clinical pharmacology (01-11-1992)
    “…We have investigated whether the potential benefits of a controlled release formulation of levodopa (200 mg)/carbidopa (50 mg), Sinemet CR, are realised during…”
    Get full text
    Journal Article
  8. 8

    Measurement of Compliance with Medication: The sine qua non of Clinical Trials in Old Age? by O'NEILL, C. J. A., DOBBS, R. J., DOBBS, S. M., NICHOLSON, P. W.

    Published in Age and ageing (01-03-1991)
    “…The use of devices for measuring the compliance with medication in the elderly is discussed. Clinical trials in older people are jeopardized by poor compliance…”
    Get full text
    Journal Article
  9. 9

    Effect of duration of levodopa/decarboxylase inhibitor therapy on the pharmacokinetic handling of levodopa in elderly patients with idiopathic Parkinson's disease by BOWES, S. G, O'NEILL, C. J. A, NICHOLSON, P. W, LEEMAN, A. L, DESHMUKH, A. A, DOBBS, R. J, DOBBS, S. M

    Published in European journal of clinical pharmacology (01-01-1991)
    “…We address, from a pharmacokinetic viewpoint, the important question of why some patients with clinical idiopathic Parkinson's disease experience a fall off in…”
    Get full text
    Journal Article
  10. 10

    Evaluation of the safety of enalapril in the treatment of heart failure in the very old by O'NEILL, C. J. A, BOWES, S. G, SULLENS, C. M, ROYSTON, J. P, HUNT, W. B, DENHAM, M. J, DOBBS, R. J, DOBBS, S. M

    Published in European journal of clinical pharmacology (01-01-1988)
    “…We have introduced enalapril, in doses equal to or less than the 2.5 mg currently recommended, as an adjuvant to digoxin and diuretics in 17 patients of mean…”
    Get full text
    Journal Article
  11. 11

    Therapeutic drug monitoring of digoxin: help or hindrance? by DOBBS, R. J, NICHOLSON, P. W, DENHAM, M. J, DOBBS, S. M, O'NEILL, C. J. A

    “…A major role of therapeutic drug monitoring services is to advise on the dose of a drug which would be required to bring the concentration in the blood to…”
    Get full text
    Journal Article
  12. 12

    GOTcha: IncRNA-ACOD1 targets metabolism during viral infection by Marah C Runtsch;Luke AJ O'Neill

    Published in 细胞研究:英文版 (2018)
    “…Long-noncoding RNAs (lncRNAs) are emerging as important regulators of cellular processes, but few have been functionally characterized in host-pathogen…”
    Get full text
    Journal Article
  13. 13

    Prescribing digoxin in geriatric units: the unexplained variability in dosage requirements by DOBBS, R. J, ROYSTON, J. P, O'NEILL, C. J. A, DESHMUKH, A. A, NICHOLSON, P. W, DENHAM, M. J, DOBBS, S. M

    Published in European journal of clinical pharmacology (01-01-1987)
    “…Some physicians regard patients of Geriatric Units as a homogeneous population with respect to digoxin dosage requirements. Others advocate the use of…”
    Get full text
    Journal Article
  14. 14

    Measurement of compliance with medication: the sine qua non of clinical trials in old age? by O'Neill, C J A, Dobbs, R J, Dobbs, S M

    Published in Age and ageing (01-03-1991)
    “…Notes the need for definitions of compliance which relate to efficacy and effectiveness. Discusses problems of measurement and devices for monitoring…”
    Get full text
    Journal Article
  15. 15

    Defining small differences in efficacy between anti‐parkinsonian agents using gait analysis: a comparison of two controlled release formulations of levodopa/decarboxylase inhibitor by Weller, C, O'Neill, CJ, Charlett, A, Bowes, SG, Purkiss, A, Nicholson, PW, Dobbs, RJ, Dobbs, SM

    Published in British journal of clinical pharmacology (01-04-1993)
    “…1. Stride length is highly relevant to mobility and is sensitive to the effects of levodopa in Parkinsonism. Its selection as the primary outcome criterion…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Determinants of gait in the elderly parkinsonian on maintenance levodopa/carbidopa therapy by Bowes, SG, Clark, PK, Leeman, AL, O'Neill, CJ, Weller, C, Nicholson, PW, Deshmukh, AA, Dobbs, SM, Dobbs, RJ

    Published in British journal of clinical pharmacology (01-07-1990)
    “…1. We have used gait analysis to investigate the efficacy of maintenance therapy with a levodopa/carbidopa combination in patients with idiopathic…”
    Get full text
    Journal Article
  18. 18

    Could seborrhoeic dermatitis be implicated in the pathogenesis of parkinsonism? by O'Neill, C J, Richardson, M D, Charlett, A, McHugh, L, Bowes, S G, Purkiss, A G, Weller, C, Dobbs, S M, Dobbs, R J

    Published in Acta neurologica Scandinavica (01-04-1994)
    “…The spouses of a group of aged sufferers have been demonstrated to have multifarious differences relevant to parkinsonism from matched controls, which were…”
    Get more information
    Journal Article
  19. 19
  20. 20

    A quinine a day keeps the leg cramps away? by Warburton, A, Royston, JP, O'Neill, CJ, Nicholson, PW, Jee, RD, Denham, MJ, Dobbs, SM, Dobbs, RJ

    Published in British journal of clinical pharmacology (01-04-1987)
    “…A double‐blind, placebo‐controlled, cross‐over trial of quinine in leg cramps occurring at rest was conducted in 22 elderly cramp sufferers. Despite…”
    Get full text
    Journal Article